| Atritech News | |
Atritech announces FDA Regulatory Update Atritech completes $30 million financing Atritech to participate in late breaking clinical trial presentation at American College of Cardiology meeting Atritech files pre-market approval application for its WATCHMAN® LAA Closure Technology Atritech announces completion of a $22 million equity financing Atritech announces acquisition of IP |
Read Story